论文部分内容阅读
Phase Ⅲ randomized controlled study of daratumumab,bortezomib,and dexamethasone(DVd)versus bortezomi
【作 者】
:
【机 构】
:
University of Torino,Torino,Italy Mayo Clinic Flo
【出 处】
:
2016年临床肿瘤学新进展学术研讨会
【发表日期】
:
2016年5期
其他文献
PILLAR-2:A randomized,double-blind,placebo-controlled,phase Ⅲ study of adjuvant everolimus(EVE)in pa
会议
Two years rituximab maintenance vs.observation after first-line treatment with bendamustine plus rit
会议
Upfront autologous stem cell transplantation(ASCT)versus novel agent-based therapy for multiple myel
会议
Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOT
会议
Overall survival(OS)in patients(pts)with platinum-sensitive relapsed serous ovarian cancer(PSR SOC)r
会议
Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal c
会议
Updated results from a phase Ⅲ trial of nivolumab(NIVO)combined with ipilimumab(IPI)in treatment-nai
会议
会议